Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Haddad

Showing results (641-650 of 698) with videos related to

Pageof 70
Sort By:
Alzheimer Disease and Associated Disorders|March 16, 2022
Screening for Dementia and Cognitive Decline in Adults With Down Syndrome: A Novel Approach Using the Informant Questionnaire on Cognitive Decline in the ElderlyGuilherme Prado Mattar, Ricardo R Uchida, Glenda G Haddad, et al.
The Journal of Emergency Medicine|March 11, 2016
A Cross-Sectional Study of Medical Student Knowledge of Evidence-Based Medicine as Measured by the Fresno Test of Evidence-Based MedicineAmy B Smith, Lauren Semler, Elizabeth A Rehman, et al.
Molecular Biology and Evolution|October 14, 2017
New Insights into the Genetic Basis of Monge's Disease and Adaptation to High-AltitudeTsering Stobdan, Ali Akbari, Priti Azad, et al.
Leukemia & Lymphoma|May 15, 2024
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemiaJennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, et al.
Journal of Biomolecular Structure & Dynamics|January 17, 2023
<i>Rhizophora mucronata</i> Lam., a halophyte from Mauritius Island, inhibits the entry of Zika virus in human cells (A549)- an <i>in vitro</i> and <i>in silico</i> analysisNabeelah Bibi Sadeer, Juliano G Haddad, Mohammed Oday Ezzat, et al.
Nature Metabolism|July 1, 2024
Time of sample collection is critical for the replicability of microbiome analysesCeleste Allaband, Amulya Lingaraju, Stephany Flores Ramos, et al.
International Journal of Geriatric Psychiatry|February 27, 2020
Amnestic and non-amnestic symptoms of dementia: An international study of Alzheimer's disease in people with Down's syndromeLuciana M Fonseca, Concepcion Padilla, Elizabeth Jones, et al.
Blood|October 25, 2023
Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remissionElias Jabbour, Fadi G Haddad, Nicholas J Short, et al.
American Journal of Hematology|July 24, 2023
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib eraFadi G Haddad, Koji Sasaki, Aram Bidikian, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 11, 2024
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic LeukemiaNicholas J Short, Elias Jabbour, Trevor Jamison, et al.
Pageof 70

Showing results (641-650 of 698) with videos related to

Sort By:
Pageof 70
Alzheimer Disease and Associated Disorders|March 16, 2022
Screening for Dementia and Cognitive Decline in Adults With Down Syndrome: A Novel Approach Using the Informant Questionnaire on Cognitive Decline in the ElderlyGuilherme Prado Mattar, Ricardo R Uchida, Glenda G Haddad, et al.
The Journal of Emergency Medicine|March 11, 2016
A Cross-Sectional Study of Medical Student Knowledge of Evidence-Based Medicine as Measured by the Fresno Test of Evidence-Based MedicineAmy B Smith, Lauren Semler, Elizabeth A Rehman, et al.
Molecular Biology and Evolution|October 14, 2017
New Insights into the Genetic Basis of Monge's Disease and Adaptation to High-AltitudeTsering Stobdan, Ali Akbari, Priti Azad, et al.
Leukemia & Lymphoma|May 15, 2024
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemiaJennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, et al.
Journal of Biomolecular Structure & Dynamics|January 17, 2023
<i>Rhizophora mucronata</i> Lam., a halophyte from Mauritius Island, inhibits the entry of Zika virus in human cells (A549)- an <i>in vitro</i> and <i>in silico</i> analysisNabeelah Bibi Sadeer, Juliano G Haddad, Mohammed Oday Ezzat, et al.
Nature Metabolism|July 1, 2024
Time of sample collection is critical for the replicability of microbiome analysesCeleste Allaband, Amulya Lingaraju, Stephany Flores Ramos, et al.
International Journal of Geriatric Psychiatry|February 27, 2020
Amnestic and non-amnestic symptoms of dementia: An international study of Alzheimer's disease in people with Down's syndromeLuciana M Fonseca, Concepcion Padilla, Elizabeth Jones, et al.
Blood|October 25, 2023
Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remissionElias Jabbour, Fadi G Haddad, Nicholas J Short, et al.
American Journal of Hematology|July 24, 2023
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib eraFadi G Haddad, Koji Sasaki, Aram Bidikian, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 11, 2024
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic LeukemiaNicholas J Short, Elias Jabbour, Trevor Jamison, et al.
Pageof 70